ELVAF Stock - Evolva Holding S.A.
Unlock GoAI Insights for ELVAF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $9.44M | $15.54M | $9.88M | $7.54M |
| Gross Profit | N/A | $-2,583,000 | $-1,549,200 | $-9,305,900 | $-2,242,000 |
| Gross Margin | N/A | -27.4% | -10.0% | -94.2% | -29.7% |
| Operating Income | $788,700 | $-92,245,000 | $-40,392,000 | $-42,029,000 | $-24,905,000 |
| Net Income | $1.04M | $-105,229,000 | $-43,366,000 | $-41,266,000 | $-29,870,000 |
| Net Margin | N/A | -1115.0% | -279.1% | -417.8% | -396.1% |
| EPS | $0.14 | $-19.50 | $-10.13 | $-11.72 | $-9.49 |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Visit WebsiteEarnings History & Surprises
ELVAFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 19, 2026 | — | — | — | — |
Q3 2025 | Aug 21, 2025 | — | — | — | — |
Q1 2025 | Feb 21, 2025 | — | $-0.08 | — | — |
Q4 2024 | Oct 21, 2024 | — | $0.21 | — | — |
Q2 2024 | Apr 12, 2024 | — | $-2.55 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-19.62 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-3.51 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-6.84 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-4.60 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-8.14 | — | — |
Q4 2020 | Dec 31, 2020 | $-5.66 | $-5.83 | -3.0% | ✗ MISS |
Q2 2020 | Jun 30, 2020 | — | $-4.59 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-3.72 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-3.40 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-4.61 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-5.03 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-8.47 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-13.03 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-9.96 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-12.81 | — | — |
Latest News
Frequently Asked Questions about ELVAF
What is ELVAF's current stock price?
What is the analyst price target for ELVAF?
What sector is Evolva Holding S.A. in?
What is ELVAF's market cap?
Does ELVAF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ELVAF for comparison